Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort

Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as they may present with respiratory muscle weakness and because they are on immunosuppressive treatment; thereby, COVID-19 may have a detrimental effect on these patients. Vaccines against COVID-19 are currently ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupica, Antonino, Di Stefano, Vincenzo, Iacono, Salvatore, Pignolo, Antonia, Quartana, Martina, Gagliardo, Andrea, Fierro, Brigida, Brighina, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149833/
https://www.ncbi.nlm.nih.gov/pubmed/35645352
http://dx.doi.org/10.3390/neurolint14020033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149833/
https://www.ncbi.nlm.nih.gov/pubmed/35645352
http://dx.doi.org/10.3390/neurolint14020033

Ejemplares similares